Healthcare provider profile · identity verified

Todd A Weisman, MD

Family Practice · HAMPTON, VA · NPI 1558336867

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	802	233
Amlodipine Besylate	Amlodipine Besylate	704	192
Rosuvastatin Calcium	Rosuvastatin Calcium	373	108
Levothyroxine Sodium	Levothyroxine Sodium	348	82
Losartan Potassium	Losartan Potassium	343	94
Metoprolol Succinate	Metoprolol Succinate	292	77
Hydrochlorothiazide	Hydrochlorothiazide	281	86
Omeprazole	Omeprazole	270	78
Lisinopril	Lisinopril	237	62
Metformin Hcl	Metformin Hcl	225	65
Pravastatin Sodium	Pravastatin Sodium	217	66
Pantoprazole Sodium	Pantoprazole Sodium	210	64
Ezetimibe	Ezetimibe	207	68
Furosemide	Furosemide	182	58
Metformin Hcl Er	Metformin Hcl	165	52
Potassium Chloride	Potassium Chloride	159	44
Allopurinol	Allopurinol	151	39
Fluticasone Propionate	Fluticasone Propionate	140	58
Clopidogrel	Clopidogrel Bisulfate	135	37
Tamsulosin Hcl	Tamsulosin Hcl	132	42
Metoprolol Tartrate	Metoprolol Tartrate	129	37
Gabapentin	Gabapentin	124	45
Carvedilol	Carvedilol	121	31
Eliquis	Apixaban	118	26
Albuterol Sulfate Hfa	Albuterol Sulfate	116	46
Trazodone Hcl	Trazodone Hcl	108	34
Hydralazine Hcl	Hydralazine Hcl	100	27
Duloxetine Hcl	Duloxetine Hcl	97	29
Glimepiride	Glimepiride	93	23
Famotidine	Famotidine	91	32
Glipizide	Glipizide	90	26
Januvia	Sitagliptin Phosphate	87	25
Montelukast Sodium	Montelukast Sodium	85	27
Citalopram Hbr	Citalopram Hydrobromide	83	27
Warfarin Sodium	Warfarin Sodium	80	14
Sertraline Hcl	Sertraline Hcl	76	22
Pioglitazone Hcl	Pioglitazone Hcl	75	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	19
Spironolactone	Spironolactone	60	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	18
Breo Ellipta	Fluticasone/Vilanterol	53	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	51	18
Simvastatin	Simvastatin	51	17
Finasteride	Finasteride	49	12
Baclofen	Baclofen	48	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	14
Xarelto	Rivaroxaban	46	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	45	14
Trulicity	Dulaglutide	45	suppressed
Atenolol	Atenolol	44	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	suppressed
Ozempic	Semaglutide	43	suppressed
Synthroid	Levothyroxine Sodium	42	12
Tramadol Hcl	Tramadol Hcl	42	suppressed
Nitroglycerin	Nitroglycerin	38	11
Clonidine Hcl	Clonidine Hcl	37	suppressed
Meclizine Hcl	Meclizine Hcl	35	12
Ibuprofen	Ibuprofen	31	11
Prednisone	Prednisone	31	20
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Alprazolam	Alprazolam	26	suppressed
Ramipril	Ramipril	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Cephalexin	Cephalexin	25	23
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Acyclovir	Acyclovir	23	suppressed
Amoxicillin	Amoxicillin	23	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Klor-Con M20	Potassium Chloride	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	16
Valsartan	Valsartan	23	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	11
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Nystatin	Nystatin	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Rybelsus	Semaglutide	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Klor-Con M10	Potassium Chloride	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Risperidone	Risperidone	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Temazepam	Temazepam	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Naproxen	Naproxen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Azithromycin	Azithromycin	11	11
Droplet Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error